154 related articles for article (PubMed ID: 30254454)
1. Podoplanin-positive cancer-associated fibroblasts predict poor prognosis in lung cancer patients.
Hu G; Zhong K; Chen W; Wang S; Huang L
Onco Targets Ther; 2018; 11():5607-5619. PubMed ID: 30254454
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Infiltrating Podoplanin+ Fibroblasts Predict Worse Outcome in Solid Tumors.
Hu G; Wang S; Xu F; Ding Q; Chen W; Zhong K; Huang L; Xu Q
Cell Physiol Biochem; 2018; 51(3):1041-1050. PubMed ID: 30476924
[TBL] [Abstract][Full Text] [Related]
3. Activated Tumor-infiltrating Fibroblasts Predict Worse Prognosis in Breast Cancer Patients.
Hu G; Xu F; Zhong K; Wang S; Huang L; Chen W
J Cancer; 2018; 9(20):3736-3742. PubMed ID: 30405845
[No Abstract] [Full Text] [Related]
4. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.
Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451
[TBL] [Abstract][Full Text] [Related]
5. Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma.
Kubouchi Y; Yurugi Y; Wakahara M; Sakabe T; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Histopathology; 2018 Feb; 72(3):490-499. PubMed ID: 28881047
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin Expression in Cancer-associated Fibroblasts Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the Lung.
Yurugi Y; Wakahara M; Matsuoka Y; Sakabe T; Kubouchi Y; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Anticancer Res; 2017 Jan; 37(1):207-213. PubMed ID: 28011493
[TBL] [Abstract][Full Text] [Related]
7. Podoplanin-positive cancer-associated fibroblast recruitment within cancer stroma is associated with a higher number of single nucleotide variants in cancer cells in lung adenocarcinoma.
Nakasone S; Mimaki S; Ichikawa T; Aokage K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Tsuboi M; Goto K; Tsuchihara K; Ishii G
J Cancer Res Clin Oncol; 2018 May; 144(5):893-900. PubMed ID: 29511884
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 - negative subtype.
Tanaka Y; Ohno T; Kadonaga T; Kidokoro Y; Wakahara M; Nosaka K; Sakabe T; Suzuki Y; Nakamura H; Umekita Y
Breast Cancer; 2021 Jul; 28(4):822-828. PubMed ID: 33481184
[TBL] [Abstract][Full Text] [Related]
9. Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma.
Chuang WY; Yeh CJ; Chao YK; Liu YH; Chang YS; Tseng CK; Chang HK; Wan YL; Hsueh C
Int J Clin Exp Pathol; 2014; 7(8):4847-56. PubMed ID: 25197355
[TBL] [Abstract][Full Text] [Related]
10. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype.
Ono S; Ishii G; Nagai K; Takuwa T; Yoshida J; Nishimura M; Hishida T; Aokage K; Fujii S; Ikeda N; Ochiai A
Chest; 2013 Apr; 143(4):963-970. PubMed ID: 23081722
[TBL] [Abstract][Full Text] [Related]
12. Podoplanin is an important stromal prognostic marker in perihilar cholangiocarcinoma.
Obulkasim H; Shi X; Wang J; Li J; Dai B; Wu P; Wang S; Wang X; Ding Y
Oncol Lett; 2018 Jan; 15(1):137-146. PubMed ID: 29391878
[TBL] [Abstract][Full Text] [Related]
13. Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma.
Kawase A; Ishii G; Nagai K; Ito T; Nagano T; Murata Y; Hishida T; Nishimura M; Yoshida J; Suzuki K; Ochiai A
Int J Cancer; 2008 Sep; 123(5):1053-9. PubMed ID: 18546264
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.
Ito M; Ishii G; Nagai K; Maeda R; Nakano Y; Ochiai A
Chest; 2012 Jul; 142(1):151-158. PubMed ID: 22302300
[TBL] [Abstract][Full Text] [Related]
15. Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis.
Hu L; Zhang P; Mei Q; Sun W; Zhou L; Yin T
BMC Cancer; 2020 May; 20(1):424. PubMed ID: 32408907
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of combining immunohistochemical markers for cancer-associated fibroblasts in lung adenocarcinoma tissue.
Inoue C; Tamatsuki D; Miki Y; Saito R; Okada Y; Sasano H
Virchows Arch; 2019 Aug; 475(2):181-189. PubMed ID: 31134329
[TBL] [Abstract][Full Text] [Related]
17. Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer.
Schoppmann SF; Berghoff A; Dinhof C; Jakesz R; Gnant M; Dubsky P; Jesch B; Heinzl H; Birner P
Breast Cancer Res Treat; 2012 Jul; 134(1):237-44. PubMed ID: 22350732
[TBL] [Abstract][Full Text] [Related]
18. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.
Yoshida T; Ishii G; Goto K; Neri S; Hashimoto H; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Iida S; Niimi A; Nagai K; Ohe Y; Ochiai A
Clin Cancer Res; 2015 Feb; 21(3):642-51. PubMed ID: 25388165
[TBL] [Abstract][Full Text] [Related]
19. Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus.
Schoppmann SF; Jesch B; Riegler MF; Maroske F; Schwameis K; Jomrich G; Birner P
Clin Exp Metastasis; 2013 Apr; 30(4):441-6. PubMed ID: 23161183
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Podoplanin in Various Tumors.
Wang X; Wang X; Carvalho V; Wang Q; Li T; Wang J; Chen Y; Ni C; Liu S; Zhang J
Technol Cancer Res Treat; 2021; 20():15330338211038142. PubMed ID: 34510990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
